CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dyadic International, Inc. Company Snapshot
Dyadic International, Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dyadic International with three other companies in this sector in the United States: Revance Therapeutics Inc (2015 sales of $300,000.00 of which 100% was Botulinum Toxin Products), American Cryostem Corp ($338,910.00 ), and Zosano Pharma Corp ($313,000.00 of which 100% was Human Pharmaceutical Products).

Sales Analysis. Sales fell dramatically in 2015: Dyadic International reported sales of $315,712.00 for the year ending December of 2015. This represents a sharp decrease of 97.5% versus 2014, when the company's sales were $12.52 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dyadic International, Inc.
  Stock Performance Chart for Dyadic International, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): 1.41
(Figures in U.S. Dollars)
1 Week -4.1%   13 Weeks -1.4%  
4 Weeks -14.5%   52 Weeks 58.4%  
 
Dyadic International, Inc. Key Data:
  Ticker: DYAI Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 315,712
(Year Ending Jan 2016).
Employees: 57
  Currency: U.S. Dollars Market Cap: 52,032,098
  Fiscal Yr Ends: December Shares Outstanding: 36,902,197
  Share Type: Common Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.